Advertisement

Topics

Corneal Conditions Corporate

17:09 EST 14th November 2018 | BioPortfolio

Myonexus Therapeutics

Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for limb girdle muscular dystrophies (LGMDs) based on research at Nationwide Children’s Hospital, a leader in neuromuscular gene therapy discovery and translational research. Myonexus Therapeutics’ pipeline includes three clinical stage g...

JAR of Hope

JAR of Hope was founded in 2013 by James Raffone, after his young son, Jamesy, was diagnosed with Duchenne muscular dystrophy. Duchenne is a form of muscular dystrophy that is caused by a mutation in the dystrophin gene. The absence of dystrophin results in muscle deterioration—leading to paralysis, decreased cardiac function, and eventual death. Duch...

Cohen Laser & Vision Center

The Cohen Laser and Vision Center is a state-of-the-art eye care facility located just off I-95 in Boca Raton, Florida. Since 1985, G. Richard Cohen, MD, a Board-Certified Cornea Specialist, has been our medical director and head LASIK eye surgeon. Dr. Cohen has been providing Floridians and patients across the United States and around the World with world...

Little Hercules Foundation and Team Joseph

Little Hercules Foundation is a registered, non-profit 501(c)(3) organization based in Dublin, Ohio. Little Hercules Foundation got its start in January 2013 when three moms, two of whom had sons diagnosed with Duchenne Muscular Dystrophy, decided to host events to help fund research. Since then, Little Hercules Foundation has grown into much more. We focu...

Nightstar Therapeutics plc

Nightstar is a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases including choroideremia, X-linked retinitis pigmentosa and Best vitelliform macular dystrophy.

Lattice Biologics Ltd.

Lattice Biologics Ltd. is an emerging precision medicine leader in the field of cellular therapies and tissue engineering, with an emphasis on bone, skin, and cartilage regeneration. As a manufacturer of the highest quality allografts, Lattice is focused on next generation products to improve surgical outcomes.

Lattice Biologics

Lattice Biologics Ltd. is an emerging precision medicine leader in the field of cellular therapies and tissue engineering, with an emphasis on bone, skin, and cartilage regeneration. As a manufacturer of the highest quality allografts, Lattice is focused on next generation products to improve surgical outcomes.

Aziyo Biologics, Inc.

Aziyo Biologics, Inc. was formed by HighCape Partners, Deerfield Management Co. and KeraLink International with the mission of restoring health and mobility to the greatest number of patients. Aziyo’s vision is to impact healthcare through innovation of new solutions realizing the commercial potential of regenerative medicine. KeraLink is one of th...

Santhera Pharmaceuticals Holding Ltd

Santhera Pharmaceuticals is a Swiss biopharmaceutical company focusing on the discovery, development and marketing of small molecule pharmaceutical products for the treatment of neuromuscular diseases. Santhera’s vision is to become the leading specialty pharmaceuticals company offering therapies for a number of indications in this area of high unmet medical need which includes many orphan indic...

Goodix

Goodix, a premier developer and provider of fingerprint and touchscreen solutions for mobile phones, tablets and wearables, currently holds a diversified portfolio of fingerprint authentication solutions that provides excellent flexibility to suit the varying preferences from consumers and partners such as Live Finger DetectionTM , Invisible Fing...

Biotechnology Industry Organization (BIO) and Parent Project Muscular Dystrophy (PPMD)

SiBEAM, Inc.

SiBEAM is a pioneer in developing intelligent millimeter wave technologies for wireless communications. The company was the first to build 60GHz chipsets using standard CMOS technology. SiBEAM is a global leader in driving next-generation architecture and semiconductor implementation of wireless connectivity solutions in the consumer electronics, mobile, e...

Summit Therapeutics plc

Summit is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease Duchenne muscular dystrophy and the infectious disease Clostridium difficile infection.

Prosensa Holding N.V.

Prosensa is a Dutch biotechnology company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders. Its primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington’s disease.

Tivorsan Pharmaceuticals, Inc.

Tivorsan Pharmaceuticals, Inc. is a protein therapeutics company pioneering a unique approach to treating serious neuromuscular disorders, including DMD and Becker Muscular Dystrophy (BMD). This method, using recombinant human biglycan, is based on 25 years of basic science work in the Fallon laboratory at Brown University, Providence, RI. Tivorsan was for...

Tauber Eye Center

Dr. Joseph Tauber specializes in anterior segment surgery, corneal transplantation, the treatment of corneal and external diseases and laser vision correction procedures. A board-certified ophthalmologist, Dr. Tauber received his doctorate from Harvard Medical School, his training in internal medicine at Beth Israel Hospital and in ophthalmology at Tufts-New England Medical Center, all located in ...

NanoViricides, Inc.

NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral dis...

IntraLase Corp

LASIK eye surgery has been a safe and effective procedure for years. But it wasn’t all it could be, especially Step One where rare complications, due to the use of a hand-held microkeratome, were reported. IntraLase recognized the need for greater safety and precision in Step One. In answer to that, the company developed a femtosecond laser to replace mechanical microkeratomes in creating a more...

Molecular Biometrics, Inc.

Metabolomics is a complex scientific process that identifies and measures individual signals from many small molecular compounds produced during cellular metabolism. The company's novel technology platform creates a 'metabolomic profile' or 'fingerprint' of an embryo's potential viability, prior to possible embryo transfer in an IVF cycle. Metabolomic profiling provides a simultaneous evaluation o...

Sirion Therapeutics, Inc.

Herpetic Keratitis is the number one infectious cause of corneal blindness in the U.S. Herpes simplex virus infections are very common, with nearly 60% of the US population showing evidence of infection by age five. Approximately 1% of infected patients develop ocular outbreaks, with 20,000 primary cases of ocular herpes diagnosed in the US each year. After the primary infection, ocular HSV typic...

Dr. Brian Boxer Wachler

Dr. Brian S. Boxer Wachler, MD is a world-renowned eye surgeon, nationally and internationally admired for his expertise in LASIK, Keratoconus treatments, and other vision correction procedures. He founded the Boxer Wachler Vision Institute in Beverly Hills, California to further research into new vision correction procedures and provides patients with the most advanced vision care treatments. He ...

SightLife

SightLife and its partner eye banks restore sight to an average of 20 people each day around the globe through the recovery and placement of eye tissue used in cornea transplants. SightLife is also a leading partner in efforts to establish new eye banks in developing countries, where 90% of the world’s estimated 10 million corneal blind men, women, an...

Avedro, Inc.

Avedro, a privately held medical device company based in Waltham, MA, is developing the science of Thermo-biomechanics for therapeutic medical applications. Keraflex® KXL is the first technology Avedro has developed from its Thermo-biomechanics platform. Avedro recently announced it has signed a definitive agreement with Peschke Meditrade GmbH to acquir...

BI2 Technologies

BI2 Technologies is a privately held Massachusetts corporation that develops, sells, designs, implements, integrates and supports iris, fingerprint and facial biometric technologies. The Company is located in Plymouth, Massachusetts.

M2SYS Technology

M2SYS Technology, www.m2sys.com, is a recognized industry leader in fingerprint identity management technology, delivering a wide range of customized, fully functional, turn-key fingerprint software solutions for businesses and consumers. M2SYS Technology was awarded the prestigious Frost & Sullivan Biometric Technology Innovation of the Year award in 2007.

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Corneal Conditions market research data and corporate reports here